Genpact Q2 revenue up 2% to $1.11B; full-year revenue guidance cut to $4.59-4.64B

Genpact LTD

2023-Q2 EPS reported $1.19 revenue$2,194,843,000

Diluted EPS $0.63 (up 66% YoY); adjusted diluted EPS $0.72 (up 3% YoY).
Data-Tech-AI services revenue $501M (+2% YoY); Digital Operations $605M (+1% YoY).
Cash from operations $171M vs $102M a year ago; repurchased 3.2M shares for $120M.
Full-year 2023 revenue guidance lowered to $4.59-4.64B (prior $4.64-4.71B); adjusted EPS guidance narrowed to $2.91-2.94.
Management expects 2023 full-year bookings growth of 25%-30% driven by large deals and new logos.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Genpact LTD reported the second quarter ended June 30, 2023 results: revenue $1.106 billion, net income $116 million, EPS $0.63. Guidance lowered.

Period: the second quarter ended June 30, 2023
Revenue: $1.106 billion
Net income: $116 million
EPS: $0.63
Guidance: lowered
Result: reported results

Exact text from the filing

Genpact Reports Second Quarter 2023 Results Total revenue of $1.106 billion, Up 2% (3% constant currency) 1,2 Data-Tech-AI services revenue of $501 million, Up 2% (3% constant currency) 1,2 Digital Operations services revenue of $605 million, Up 1% (2% constant currency) 1 Diluted EPS of $0.63, Up 66%; Adjusted Diluted EPS 3 of $0.72, Up 3% NEW YORK, August 9, 2023 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering outcomes that transform businesses, today announced financial results for the second quarter ended June 30, 2023.

View on SEC.gov

Browse all earnings releases →

Genpact LTD filing history →

Source: SEC EDGAR

accession 0001398659-23-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.